Herb-drug interactions in oncology: focus on mechanisms of induction
about
Flavonoids and Wnt/β-catenin signaling: potential role in colorectal cancer therapiesRole of pregnane X receptor in chemotherapeutic treatmentAqueous cinnamon extract (ACE-c) from the bark of Cinnamomum cassia causes apoptosis in human cervical cancer cell line (SiHa) through loss of mitochondrial membrane potentialLiver toxicity during temozolomide chemotherapy caused by Chinese herbs.Traditional Chinese medicine use among Chinese immigrant cancer patients.Performance of different data sources in identifying adverse drug events in hospitalized patients.Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.Inhibition of Human Cytochrome P450 Enzymes by Allergen Removed Rhus verniciflua Stoke Standardized Extract and Constituents.Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review.Toxicity of kava kava.Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations.Characteristics and health perceptions of complementary and alternative medicine users in the United States.Exploring the decision to disclose the use of natural products among outpatients: a mixed-method study.Use of complementary and alternative medicine by patients with cancer.Use of Complementary and Alternative Medicine in Children with Cancer: A Study at a Swiss University Hospital.An overview of the evidence and mechanisms of herb-drug interactions.An assessment of the impact of herb-drug combinations used by cancer patients.A consultation training program for physicians for communication about complementary medicine with breast cancer patients: a prospective, multi-center, cluster-randomized, mixed-method pilot study.Pharmacokinetics of eribulin mesylate in patients with solid tumours receiving repeated oral rifampicinLesson from comparison of CAM use by women with female-specific cancers to others: it's time to focus on interaction risks with CAM therapies.Safety and pharmacokinetic trial of docetaxel plus an Astragalus-based herbal formula for non-small cell lung cancer patientsIdentification of polymorphisms in the 3'-untranslated region of the human pregnane X receptor (PXR) gene associated with variability in cytochrome P450 3A (CYP3A) metabolism.Effects of pharmaceuticals and other active chemicals at biological targets: mechanisms, interactions, and integration into PB-PK/PD models.Cytochrome P450 and P-Glycoprotein-Mediated Interactions Involving African Herbs Indicated for Common Noncommunicable Diseases.Pregnane X receptor is associated with unfavorable survival and induces chemotherapeutic resistance by transcriptional activating multidrug resistance-related protein 3 in colorectal cancer.Effects of herbal products on the metabolism and transport of anticancer agents.Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters.Combination therapy of Western drugs and herbal medicines: recent advances in understanding interactions involving metabolism and efflux.Drug-vitamin D interactions: a systematic review of the literatureInteractions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.Pharmacokinetic Herb-Drug Interactions: Insight into Mechanisms and Consequences.IFN-γ regulates cytochrome 3A29 through pregnane X receptor in pigs.Complementary and Alternative Medicine Use in Cancer Patients in Rural Australia.A Survey of Licensed Acupuncturists in the San Francisco Bay Area: Prevalence of Treating Oncology Patients.Intra-herb pharmacokinetics interaction between quercetin and isorhamentin.Potential risks associated with traditional herbal medicine use in cancer care: A study of Middle Eastern oncology health care professionals.Evaluation of a Patient CAM-with-Chemotherapy Educational Brochure.An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM).Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients.Post-transcriptional regulation of human pregnane X receptor by micro-RNA affects the expression of cytochrome P450 3A4.
P2860
Q26825474-CBC9533A-E535-4DFE-9CCD-1D0178E40A2DQ26827398-07C173FE-2191-4685-9980-B6A28E1C3500Q30495171-C40C7A30-C010-4C23-8051-116487836F4BQ31154896-E459D1B4-CB5D-4816-B01F-FB33DF3516F8Q33612897-19BCA72C-D4D4-42B5-B937-CFC1A7AA3E2FQ33843430-8551CC0B-79BB-4118-8509-7031E7D40C69Q33861639-62140D45-25D5-4C31-81E4-11BECE823FF5Q33908260-FA91AEAC-533B-4B07-9219-C0DCCCF71005Q34306204-682F0ADB-4884-4D0B-A622-B41146680BC8Q34759111-BC67174E-8F40-44E4-A581-7BC06FAAB915Q35009679-6772401F-68C7-47CE-8AAB-83008C0B8254Q35033640-259C77FE-D57F-47A3-95D8-63E4A7FDD3C1Q35045626-20C4D430-66A3-42AA-8FF3-6701D6F17D56Q35252053-6D4D6C98-CF0F-4BB2-ABA0-BEF8289D889CQ35875453-C902BE4D-DD7E-4F8B-95DD-5A8D7350383FQ35919968-03268076-3EFD-4195-B91E-93B74A553779Q36166875-CE644E09-CD30-4F68-B033-0A0A2443354AQ36181462-DF806CE7-1B5F-407C-B1DF-5AE1B2F5693AQ36629243-57F250B5-5FB8-4C23-A3AC-072CF46DDBA1Q37019717-4D5682E5-FEC7-4AE5-8AF3-1E8946577ACDQ37102914-69112E92-5FDF-46FD-B18C-8C8648FEE24AQ37207247-AAFEC4D1-05CE-4B62-96A1-A1935C201CD5Q37521097-D46E911F-0EB2-4366-81EF-E420A7A34AE2Q37640084-41DE8DFB-CA5D-4C65-83E3-A594BCBD473EQ37728678-44EF1641-D5DB-4C8C-93BC-9AFF54CCD8C2Q37779320-ACCB7B87-5424-4DE8-83F0-9B0F92AE22F4Q37993631-6AD5706C-B6DE-4B19-82AE-05A474649A37Q38011807-0107AA13-5232-40DD-BEB3-9358DF0AC5FDQ38073239-7D6E28C7-B6A6-4C6F-A421-60C82464EF56Q38283110-30FCA3D7-EF8D-4B86-B174-28E05BA6D275Q38574619-BD905C36-80BB-43F0-8D75-6262CC037F4DQ38938781-F4BEEB62-7071-4FBA-B504-529D364B6796Q39018161-51D74FD0-5D24-4336-B45D-C6AE6574F518Q39038022-05F7075D-57ED-45EA-A178-B700817DE620Q39924679-BB0A5427-DBB6-43C5-B6D7-98136C9DE885Q40283529-856D1B84-B8BF-41C5-837C-31E055C23913Q43179854-29FEF7F8-B306-467A-9F18-F4219291AF80Q46304316-A982E37B-45AD-465D-906A-8676F8143577Q46675810-B2797470-1C5B-404B-99B2-BAC92CF0BC33Q46759040-81AB6C46-F3BD-4E9F-B8CA-683C1B3EFE1B
P2860
Herb-drug interactions in oncology: focus on mechanisms of induction
description
2006 nî lūn-bûn
@nan
2006 թուականին հրատարակուած գիտական յօդուած
@hyw
2006 թվականին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Herb-drug interactions in oncology: focus on mechanisms of induction
@ast
Herb-drug interactions in oncology: focus on mechanisms of induction
@en
Herb-drug interactions in oncology: focus on mechanisms of induction
@nl
type
label
Herb-drug interactions in oncology: focus on mechanisms of induction
@ast
Herb-drug interactions in oncology: focus on mechanisms of induction
@en
Herb-drug interactions in oncology: focus on mechanisms of induction
@nl
prefLabel
Herb-drug interactions in oncology: focus on mechanisms of induction
@ast
Herb-drug interactions in oncology: focus on mechanisms of induction
@en
Herb-drug interactions in oncology: focus on mechanisms of induction
@nl
P2093
P3181
P1433
P1476
Herb-drug interactions in oncology: focus on mechanisms of induction
@en
P2093
Irma Meijerman
Jan H M Schellens
Jos H Beijnen
P304
P3181
P356
10.1634/THEONCOLOGIST.11-7-742
P407
P577
2006-01-01T00:00:00Z